JPY 928.0
(-0.85%)
Breakdown | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Operating Cash Flow | 319.36 Million | 350.87 Million | 42.5 Million | -15.83 Million |
Net Income | 215.68 Million | 239.83 Million | -8.42 Million | -177.7 Million |
Depreciation & Amortization | 34.21 Million | 15.95 Million | 7.59 Million | 6.91 Million |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | -6.45 Million | 96.53 Million | 39.76 Million | 152.34 Million |
Other non-cash items | 106.65 Million | -1.16 Million | 4.09 Million | 3.4 Million |
Investing Cash Flow | -182.4 Million | -38.16 Million | -6.51 Million | 6.49 Million |
Investments in PPE | -63.65 Million | -55.83 Million | -7.69 Million | -4.29 Million |
Acquisitions | -118.74 Million | 64 Thousand | - | - |
Investment purchases | - | - | - | -330 Thousand |
Sales/Maturities of investments | - | - | 1.18 Million | 11.12 Million |
Other Investing Activities | -2000.00 | 17.6 Million | 1.18 Million | -1000.00 |
Financing Cash Flow | 232.3 Million | - | 142.25 Million | 21.83 Million |
Debt repayment | -182.99 Million | - | - | - |
Dividends payments | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Common Stock Issuance | 49.3 Million | - | 142.34 Million | 21.83 Million |
Other Financing Activities | 50 Million | - | -90 Thousand | - |
Accounts receivables | 7.96 Million | 13 Million | -39.23 Million | -8.72 Million |
Accounts payables | 30.55 Million | 8.16 Million | 7.99 Million | 22.93 Million |
Inventory | -832 Thousand | 710 Thousand | 278 Thousand | -999 Thousand |
Other working capital | -44.13 Million | 53 Million | 74.2 Million | 142.24 Million |
Cash at beginning of period | 1.24 Billion | 934.95 Million | 756.71 Million | 744.21 Million |
Cash at end of period | 1.61 Billion | 1.24 Billion | 934.95 Million | 756.71 Million |
Capital Expenditure | -63.65 Million | -55.83 Million | -7.69 Million | -4.29 Million |
Effect of forex changes on cash | - | - | - | - |
Net cash flow / Change in cash | 369.26 Million | 312.71 Million | 178.24 Million | 12.5 Million |
Free Cash Flow | 255.7 Million | 295.04 Million | 34.81 Million | -20.12 Million |
Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 215.68 Million | 21 Million | 52 Million | 80 Million | 62 Million | 141 Million |
Depreciation & Amortization | 34.21 Million | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -6.45 Million | - | - | - | - | - |
Other non-cash items | 106.65 Million | -21 Million | -52 Million | -80 Million | -62 Million | -141 Million |
Investing Cash Flow | -182.4 Million | - | - | - | - | - |
Investments in PPE | -63.65 Million | - | - | - | - | - |
Acquisitions | -118.74 Million | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -2000.00 | - | - | - | - | - |
Financing Cash Flow | 232.3 Million | - | - | - | - | - |
Debt repayment | -182.99 Million | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 49.3 Million | - | - | - | - | - |
Other Financing Activities | 50 Million | - | - | - | - | - |
Accounts receivables | 7.96 Million | - | - | - | - | - |
Accounts payables | 30.55 Million | - | - | - | - | - |
Inventory | -832 Thousand | - | - | - | - | - |
Other working capital | -44.13 Million | - | - | - | - | - |
Cash at beginning of period | 1.24 Billion | - | - | - | - | - |
Cash at end of period | 1.61 Billion | - | - | - | - | - |
Capital Expenditure | -63.65 Million | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 369.26 Million | - | - | - | - | - |
Free Cash Flow | 255.7 Million | - | - | - | - | - |
CUB
GBBKR
7792
AUTN
PANACEABIO
5610